The BrightStar Wisconsin Foundation, a nonprofit foundation dedicated to facilitating job creation and increasing Wisconsin’s economic activity, has invested in Phoenix-Aid, an Oshkosh-based medical device company developing a wound care technology designed to accelerate healing and reduce infections for patients with diabetic foot ulcers and other chronic wounds.
Phoenix-Aid has developed a “nano composite matrix” that would replace gauze and ointment wraps. The company’s goal is to “accelerate healing, block infections and comfort the patient and the wound,” BrightStar said in a statement.
Phoenix-Aid is running biocompatibility animal studies in Madison and will run a clinical trial in India early next year.
“BrightStar is excited to support a Wisconsin-born technology that has the potential to dramatically improve health outcomes both globally and in rural, underserved communities where access to quality wound care remains limited,” Maximillian Hartounian, BrightStar’s business manager, said in a statement.
